FR2043477A1 - Magnesium thenoate - Google Patents

Magnesium thenoate

Info

Publication number
FR2043477A1
FR2043477A1 FR6916442A FR6916442A FR2043477A1 FR 2043477 A1 FR2043477 A1 FR 2043477A1 FR 6916442 A FR6916442 A FR 6916442A FR 6916442 A FR6916442 A FR 6916442A FR 2043477 A1 FR2043477 A1 FR 2043477A1
Authority
FR
France
Prior art keywords
magnesium
thenoate
dyskinesis
prepd
biliary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6916442A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INVESTIGATIONS SCI PHARM
Original Assignee
INVESTIGATIONS SCI PHARM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INVESTIGATIONS SCI PHARM filed Critical INVESTIGATIONS SCI PHARM
Priority to FR6916442A priority Critical patent/FR2043477A1/en
Publication of FR2043477A1 publication Critical patent/FR2043477A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic System
    • C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic System without C-Metal linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Magnesium thenoate (I), prepd. by the action of magnesium hydroxide on thenoic acid, is useful in the treatment of respiratory infections, allergic states, magnesium and sulphur deficiency, hepatic insufficiency and biliary dyskinesis.
FR6916442A 1969-05-20 1969-05-20 Magnesium thenoate Withdrawn FR2043477A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR6916442A FR2043477A1 (en) 1969-05-20 1969-05-20 Magnesium thenoate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6916442A FR2043477A1 (en) 1969-05-20 1969-05-20 Magnesium thenoate

Publications (1)

Publication Number Publication Date
FR2043477A1 true FR2043477A1 (en) 1971-02-19

Family

ID=9034356

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6916442A Withdrawn FR2043477A1 (en) 1969-05-20 1969-05-20 Magnesium thenoate

Country Status (1)

Country Link
FR (1) FR2043477A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2411188A1 (en) * 1977-12-12 1979-07-06 Parcor Anti-spasmophilic magnesium 2-and 3-thenoyl glycinate(s) - are prepd. from glycine and thenoyl halide followed by magnesium hydroxy-carbonate
FR2420972A1 (en) * 1978-03-31 1979-10-26 Roussel Uclaf APPLICATION OF THENOYL PEROXIDE AS A MEDICINAL PRODUCT

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2411188A1 (en) * 1977-12-12 1979-07-06 Parcor Anti-spasmophilic magnesium 2-and 3-thenoyl glycinate(s) - are prepd. from glycine and thenoyl halide followed by magnesium hydroxy-carbonate
FR2420972A1 (en) * 1978-03-31 1979-10-26 Roussel Uclaf APPLICATION OF THENOYL PEROXIDE AS A MEDICINAL PRODUCT
EP0004810A3 (en) * 1978-03-31 1979-10-31 Roussel-Uclaf Application of thenoyl peroxide as a medicine as well as cosmetically, pharmaceutical and cosmetical compositions containing it

Similar Documents

Publication Publication Date Title
GB1372888A (en) Liquid detergent compositions
FR2043477A1 (en) Magnesium thenoate
FR2066093A5 (en) Suppressing calcium ions in developer
AT316280B (en) Process for the production of an open, essentially C-shaped base body
ZA707394B (en) Process for the treatment of aqueous effluents bearing coating compositions
ES275328A1 (en) Antibiotics and their purification
BE755067A (en) AQUEOUS POLYMERISATE DISPERSIONS, CONTAINING P-AMINOBENZOIC ACID DERIVATIVES
FR2068444A1 (en) Calcium magnesium bromolactobionate
FR1867M (en) New composition intended in particular for the treatment of cholesterolemia.
FR2104911A1 (en) Heterosides from ruscus aculeatus l - useful as antiinflammatories vasconstructors and fibrinolytics
AU525754B2 (en) Migraine treatment
FR2073832A5 (en) Preventing precipitation of calcium ions in - developer
ES318642A1 (en) Treatment of polyamides
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
CA941529A (en) Treatment of an aqueous waste stream
BE616449A (en) Improvements in processes for the production of itaconic acid and its salts.
FR2034233A1 (en) Antibacterial antiviral disinfectant bath - comp
CA846228A (en) Deodorizing treatment of aqueous solutions
AU259000B2 (en) Process forthe purification of water and/or the concentration of aqueous solutions
CA809474A (en) Treating gelatinous solutions
ZA707266B (en) Treatment of an aqueous waste stream
CA802109A (en) Treatment of aqueous alkaline aluminate solution
KR790000168B1 (en) Salts of 2,6-dioxocyclohexane thiocarboxylic acid 4'-halo-anilides and pharmaceutical compositions
CA941528A (en) Treatment of an aqueous waste stream containing ammonium hydroxide
CA829662A (en) Reducing the pressure on aqueous solutions of polymers

Legal Events

Date Code Title Description
ST Notification of lapse